HomeANRO • NYSE
add
Alto Neuroscience Inc
Previous close
$4.60
Day range
$4.36 - $4.68
Year range
$3.61 - $24.00
Market cap
121.85M USD
Avg Volume
1.23M
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 18.89M | 94.34% |
Net income | -16.78M | -83.60% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -18.76M | -94.34% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 181.70M | — |
Total assets | 191.61M | — |
Total liabilities | 26.56M | — |
Total equity | 165.05M | — |
Shares outstanding | 26.97M | — |
Price to book | 0.75 | — |
Return on assets | -24.28% | — |
Return on capital | -25.55% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -16.78M | -83.60% |
Cash from operations | -11.73M | -51.01% |
Cash from investing | -1.00M | -2,237.21% |
Cash from financing | 1.32M | 2,587.76% |
Net change in cash | -11.42M | -47.54% |
Free cash flow | -9.48M | — |
About
Founded
2019
Website
Employees
88
